Sugi Predict

Sugi Predict / Compounds / SCHEMBL147665

SCHEMBL147665

SCHEMBL147665

CCCCCCCCCCC[C@H](CC(=O)O)OCCCCCCCCCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR84 Q9NQS5 5/20 0.55
▸ DNM1 Q05193 1/20 0.47
▸ TLR2 O60603 2/20 0.46
▸ MAPK1 P28482 4/20 0.45
▸ GMNN O75496 3/20 0.45
▸ LMNA P02545 3/20 0.45
▸ MAPT P10636 3/20 0.45
▸ NPSR1 Q6W5P4 3/20 0.45
▸ CYP1A2 P05177 2/20 0.45
▸ MEN1 O00255 2/20 0.45
▸ HSP90AA1 P07900 2/20 0.45
▸ BLM P54132 2/20 0.45
▸ KMT2A Q03164 2/20 0.45
▸ NR1H4 Q96RI1 2/20 0.45
▸ TP53 P04637 1/20 0.45
▸ CYP2C9 P11712 1/20 0.45
▸ TSHR P16473 1/20 0.45
▸ HIF1A Q16665 1/20 0.45
▸ FFAR4 Q5NUL3 1/20 0.44
▸ FFAR1 O14842 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27503997 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL2356631 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL140518 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL2356636 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL147666 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL9406666 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL2315839 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL113225 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL2678427 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN
SCHEMBL27504689 1.00 GPR84 (0.55) GPR84DNM1TLR2MAPK1GMNN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250170156-A1 TOLL-LIKE RECEPTOR LIGANDS INIMMUNE CORP (US) 2025-05-29 — — US disclosed
US-12150948-B2 Toll-like receptor ligands NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT (US) 2024-11-26 — — US disclosed
EP-4410802-A2 TOLL-LIKE RECEPTOR LIGANDS INIMMUNE CORPORATION (US) 2024-08-07 — — EP disclosed
CN-111867623-B TOLL-like receptor ligands 英尼穆内公司 2024-06-04 — — CN disclosed
EP-3752182-B1 TOLL-LIKE RECEPTOR LIGANDS INIMMUNE CORP (US) 2024-05-15 — — EP disclosed
US-20240002425-A1 NOVEL AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2024-01-04 — — US disclosed
EP-4245763-A1 NOVEL AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2023-09-20 — — EP disclosed
US-20230055805-A1 TOLL-LIKE RECEPTOR LIGANDS NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2023-02-23 — — US disclosed
US-11458151-B2 Toll-like receptor ligands INIMMUNE CORPORATION (US) 2022-10-04 — — US disclosed
WO-2022102652-A1 NOVEL AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATE DERIVATIVE 第一三共株式会社 2022-05-19 — — WO disclosed
EP-2940028-A1 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORPORATION (US) 2015-11-04 — — EP disclosed
EP-1589934-B1 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORP (US) 2015-09-23 — — EP disclosed
EP-1776375-B1 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORP (US) 2015-04-01 — — EP disclosed
US-20120058148-A1 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORPORATION (US) 2012-03-08 — — US disclosed
US-7960522-B2 Certain aminoalkyl glucosaminide phosphate compounds and their use CORIXA CORPORATION (US) 2011-06-14 — — US disclosed
EP-1776375-A2 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORPORATION (US) 2007-04-25 — — EP disclosed
WO-2006016997-A2 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORPORATION (US) 2006-02-16 — — WO disclosed
EP-1589934-A2 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORPORATION (US) 2005-11-02 — — EP disclosed
US-20050227943-A1 Certain aminoalkyl glucosaminide phosphate compounds and their use CORIXA CORPORATION (US) 2005-10-13 — — US disclosed
WO-2004062599-A2 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE CORIXA CORPORATION (US) 2004-07-29 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240002425-A1 NOVEL AMINOALKYL GLUCOSAMINIDE 4-PHOSPHATE DERIVATIVE TLR4, TLR5, TLR9 GPR84 179/4885DNM1 4516/4885TLR2 6/4885
US-20230055805-A1 TOLL-LIKE RECEPTOR LIGANDS TLR1, TLR4, TLR6 GPR84 93/4885DNM1 4206/4885TLR2 7/4885
US-11458151-B2 Toll-like receptor ligands TLR1, TLR4, TLR6 GPR84 93/4885DNM1 4206/4885TLR2 7/4885
US-12150948-B2 Toll-like receptor ligands TLR1, TLR4, TLR6 GPR84 93/4885DNM1 4206/4885TLR2 7/4885
US-20120058148-A1 CERTAIN AMINOALKYL GLUCOSAMINIDE PHOSPHATE COMPOUNDS AND THEIR USE IFNG, CD68, IL2 GPR84 672/4885DNM1 4561/4885TLR2 42/4885
US-20050227943-A1 Certain aminoalkyl glucosaminide phosphate compounds and their use IFNG, CD68, IL2 GPR84 672/4885DNM1 4561/4885TLR2 42/4885
US-20250170156-A1 TOLL-LIKE RECEPTOR LIGANDS TLR1, TLR4, TLR6 GPR84 93/4885DNM1 4206/4885TLR2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.